Protek Pharma Worldwide’s Post

We have a GDP process that reduces risk and provides a greater outcome for success in the Life Sciences. It takes a true end to end knowledge of service providers.

🌟 Biotech Industry Insight 9 Data-Driven Takeaways from the Founder Shield Report🌟 1. Market Impact: The biotech industry brings in over $150 billion each year, fueled by the rapid development of new drugs and advancements in clinical research. 2. R&D Investment: Developing a new drug costs over $2.5 billion on average, showcasing the immense financial commitment needed from initial research to FDA approval. 3. FDA Approval Odds: Only 1 in 5,000 compounds discovered in pre-clinical trials make it to FDA approval, highlighting the high stakes and thorough vetting process involved. 4. Clinical Trial Attrition: During initial drug development, 36% of compounds drop out, 60% don’t pass intermediate stages, and 40% fail in final stages, emphasizing the high attrition rates. 5. Time to Market: The FDA approval process has grown from 30 clinical trials with 1,500 patients in the early 80s to 60 trials with 5,000 patients by the mid-90s, now averaging 14 years from start to finish. 6. Patent Expiration Impact: The term “patent cliff” describes the drop in revenue many companies face when drug patents expire, typically after 20 years, allowing competitors to introduce generic versions. 7. Insurance Necessities: Biotech companies must navigate complex insurance needs, including General Liability, Product Liability, Property Insurance, and Professional & Cyber Liability, to mitigate multifaceted risks. 8. Clinical Trial Costs: Clinical trials alone can cost millions of dollars. The FDA requires extensive testing, adding significant financial pressure on biotech firms. 9. Evolving FDA Requirements: In the early 80s, potential drugs went through 30 clinical trials involving 1,500 patients. By the mid-90s, this doubled to 60 trials with 5,000 patients, and the current average time frame for new drug approval is 14 years, reflecting increased regulatory scrutiny and complexity. By leveraging these insights, biotech companies can navigate the industry's challenges and seize opportunities for innovation and growth. Ready to make a meaningful impact? Let’s connect! 💬 #Biotech #Innovation #RiskManangement

The work we do in Quality is priceless❤️ It's crucial for me to understand that quality directly influences profitability and overall success. High-quality products and services retain customers, reduce defect-related costs, and enhance the company's reputation. Keep a high-quality mindset 💪🏻 #Catalent Pharma Solutions #qualitymindset #quality

Navigating regulatory waves with finesse – because compliance is our compass. This direction will definitely lead you toward excellence. This direction will take you towards business success. This direction will take you opposite to financial losses. This direction will take you toward the future you have been waiting for long... Write me to learn more about Compliance services by Blue Ocean Compliance at rupali@blueoceancompliance.in www.drrupaliparanjape.com #drrupaliparanjape, #blueoceanofcompliance, #rupaliparanjape #cgmp, #pharmaindustry, #ceos, #founders, #manufacturers, #pharmaceuticalindustry, #qualityculture, #quality, #manufacturing, #ceomindset, #ceoinsights, #traininganddevelopment ;  #ceoaction; #ceoagenda; #foundersday; #founderstory; #owners, #ownersrepresentative, #collegesanduniversities, #pharmacycollege, #mpharm, #bpharm, #pharmacy, #mpharm, #drrupaliparanjape, #blueoceanofcompliance, #rupaliparanjape, #readers, #India

Global pharmaceutical logistics have faced significant challenges due to recent geopolitical and economic disruptions. The COVID-19 pandemic, Suez Canal blockage, and conflicts in Ukraine and Israel have all stressed supply chains, underscoring the need for more resilient logistics solutions. Adopting digital technologies like AI, IoT, and blockchain has become crucial. Strategies such as diversifying shipping routes and developing regional warehouses are essential for improving supply chain stability. What are your insights on the future of pharmaceutical logistics? How can resilience and efficiency be further enhanced? Let’s discuss!

At Wells Pharma, quality isn't just a goal; it's our guiding principle. We believe in going beyond expectations to ensure your health and satisfaction. Discover the Wells Pharma difference – where quality is more than a promise, it's our passion. #WellsPharmaQuality #HealthcareExcellence #QualityMatters #PharmacyCare #CommitmentToQuality #HealthAndWellness

Whenever I visit the ocean and look at the waves I feel that like the Ocean the world of Compliance is also so deep..... Only working superficially won't help you. Dive into the Blue Ocean of Compliance! Uncover new horizons in pharma. Working superficially means? Working superficially means only preparing at the time of Audit not every day practicing. So be in the Blue Ocean of Compliance and don't work for only survival. Do you agree with me? Write me at rupali@blueoceancompliance.in www.drrupaliparanjape.com #drrupaliparanjape, #blueoceanofcompliance, #rupaliparanjape #cgmp, #pharmaindustry, #ceos, #founders, #manufacturers, #pharmaceuticalindustry, #qualityculture, #quality, #manufacturing, #ceomindset, #ceoinsights, #traininganddevelopment ;  #ceoaction; #ceoagenda; #foundersday; #founderstory; #owners, #ownersrepresentative, #collegesanduniversities, #pharmacycollege, #mpharm, #bpharm, #pharmacy, #mpharm, #drrupaliparanjape, #blueoceanofcompliance, #rupaliparanjape

Did you know, doing repeated health checkups is also bad? S1 E4: Valeant Pharmaceuticals' aggressive accounting inflated their financial health thus crashing their stocks. Swipe through to learn more 👉 Nilotpal Chanda Raghavendra Reddy Srividhya Gurumurthi #bluecopa #financestories #copashorts

Ever considered how address validation is the unsung hero behind the booming GDP of the pharma sector? Imagine a world where your critical medication arrives late, or worse, never reaches you because of an address error. Frustrating, isn't it? Now, imagine that to a global scale. The implications are staggering. Address validation isn't just about ensuring parcels land at the right doorstep. It's a central gear in the pharmaceutical supply chain, directly influencing GDP growth. In an industry where time and accuracy are life-saving, the role of address validation stretches beyond mere logistics. It's a tale of unseen efficiency. Each successful delivery chalks up savings, reduces waste, and boosts the bottom line. This operational efficiency, in turn, fuels investment, innovation, and growth, contributing significantly to the GDP. But here's the kicker: despite its critical role, address validation is often overlooked. It's high time we acknowledged its contribution to the pharmaceutical industry's growth and, by extension, the economy. Let's start a conversation on this overlooked hero. Have you experienced the impact of address validation in your sector? Share your stories below. #pharma #medtech #quality #gmp #compliance #regulatory #zamann

What do you think 💭 on your Productivity ? Care Pharma Consultant is the company can help you to Increase your productivity with highest compliance at easy way. Our Practical experience, Postive Approach & Unique ideas can long term support you for your Productivity with minimum or no Investment. To know more about us write me on shoab@carepharmaconsultant.com OR call me on +91-9638069084. Care Pharma Consultant “Your Trust Is Our Asset”